NEW YORK (GenomeWeb) – Genomic Health reported after the close of the market Tuesday that its first quarter revenues rose 4 percent year over year, falling slightly short of the consensus Wall Street estimate.

The company's total revenue for the three months ended March 31 was $85.5 million, compared with $82.0 million in the second quarter of 2016. Analysts on average had predicted revenues of $86.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.